These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 1407412)
21. Acetylcholinesterase activity in cerebrospinal fluid of patients with Alzheimer's disease and senile dementia. Nakano S; Kato T; Nakamura S; Kameyama M J Neurol Sci; 1986 Sep; 75(2):213-23. PubMed ID: 3760912 [TBL] [Abstract][Full Text] [Related]
22. A selenium species in cerebrospinal fluid predicts conversion to Alzheimer's dementia in persons with mild cognitive impairment. Vinceti M; Chiari A; Eichmüller M; Rothman KJ; Filippini T; Malagoli C; Weuve J; Tondelli M; Zamboni G; Nichelli PF; Michalke B Alzheimers Res Ther; 2017 Dec; 9(1):100. PubMed ID: 29258624 [TBL] [Abstract][Full Text] [Related]
23. Isoelectric focusing and two-dimensional gel electrophoresis in plasma and cerebrospinal fluid from patients with dementia. Alafuzoff I; Adolfsson R; Bucht G; Jellum E; Mehta PD; Winblad B Eur Neurol; 1986; 25(4):285-9. PubMed ID: 3522239 [TBL] [Abstract][Full Text] [Related]
24. Characterization of the course of senile dementia of the Alzheimer type using cerebrospinal fluid levels of acetylcholinesterase and somatostatin. Urakami K; Adachi Y; Awaki E; Takahashi K Acta Neurol Scand; 1989 Sep; 80(3):232-7. PubMed ID: 2572139 [TBL] [Abstract][Full Text] [Related]
25. Fibrous astrocytes in Alzheimer's disease and senile dementia of Alzheimer's type. Mancardi GL; Liwnicz BH; Mandybur TI Acta Neuropathol; 1983; 61(1):76-80. PubMed ID: 6353837 [TBL] [Abstract][Full Text] [Related]
26. Cerebrospinal fluid cortisol and clinical disease progression in MCI and dementia of Alzheimer's type. Popp J; Wolfsgruber S; Heuser I; Peters O; Hüll M; Schröder J; Möller HJ; Lewczuk P; Schneider A; Jahn H; Luckhaus C; Perneczky R; Frölich L; Wagner M; Maier W; Wiltfang J; Kornhuber J; Jessen F Neurobiol Aging; 2015 Feb; 36(2):601-7. PubMed ID: 25435336 [TBL] [Abstract][Full Text] [Related]
27. Plasma and cerebrospinal fluid alpha1-antichymotrypsin levels in Alzheimer's disease: correlation with cognitive impairment. DeKosky ST; Ikonomovic MD; Wang X; Farlow M; Wisniewski S; Lopez OL; Becker JT; Saxton J; Klunk WE; Sweet R; Kaufer DI; Kamboh MI Ann Neurol; 2003 Jan; 53(1):81-90. PubMed ID: 12509851 [TBL] [Abstract][Full Text] [Related]
28. Decreased level of beta-endorphin-like immunoreactivity in cerebrospinal fluid of patients with senile dementia of Alzheimer type. Kaiya H; Tanaka T; Takeuchi K; Morita K; Adachi S; Shirakawa H; Ueki H; Namba M Life Sci; 1983 Sep; 33(11):1039-43. PubMed ID: 6310293 [TBL] [Abstract][Full Text] [Related]
29. Serum but not cerebrospinal fluid levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) are increased in Alzheimer's disease. Johansson P; Åberg D; Johansson JO; Mattsson N; Hansson O; Ahrén B; Isgaard J; Åberg ND; Blennow K; Zetterberg H; Wallin A; Svensson J Psychoneuroendocrinology; 2013 Sep; 38(9):1729-37. PubMed ID: 23473966 [TBL] [Abstract][Full Text] [Related]
30. Clusterin in cerebrospinal fluid: analysis of carbohydrates and quantification of native and glycosylated forms. Nilselid AM; Davidsson P; Nägga K; Andreasen N; Fredman P; Blennow K Neurochem Int; 2006 Jun; 48(8):718-28. PubMed ID: 16490286 [TBL] [Abstract][Full Text] [Related]
31. Increased cortisol levels in aging and Alzheimer's disease in postmortem cerebrospinal fluid. Swaab DF; Raadsheer FC; Endert E; Hofman MA; Kamphorst W; Ravid R J Neuroendocrinol; 1994 Dec; 6(6):681-7. PubMed ID: 7894471 [TBL] [Abstract][Full Text] [Related]
33. Interleukin-12 is reduced in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia. Rentzos M; Paraskevas GP; Kapaki E; Nikolaou C; Zoga M; Rombos A; Tsoutsou A; Vassilopoulos D D J Neurol Sci; 2006 Nov; 249(2):110-4. PubMed ID: 16843497 [TBL] [Abstract][Full Text] [Related]
34. Assessment of cerebrospinal fluid levels of serum amyloid P component in patients with Alzheimer's disease. Kimura M; Asada T; Uno M; Machida N; Kasuya K; Taniguchi Y; Fujita T; Nishiyama E; Iwamoto N; Arai H Neurosci Lett; 1999 Oct; 273(2):137-9. PubMed ID: 10505635 [TBL] [Abstract][Full Text] [Related]
35. Dopamine-beta-hydroxylase activities in serum and cerebrospinal fluid of aged and demented patients. Miyata S; Nagata H; Yamao S; Nakamura S; Kameyama M J Neurol Sci; 1984 Mar; 63(3):403-9. PubMed ID: 6726279 [TBL] [Abstract][Full Text] [Related]
36. IL-15 is elevated in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia. Rentzos M; Zoga M; Paraskevas GP; Kapaki E; Rombos A; Nikolaou C; Tsoutsou A; Vassilopoulos D J Geriatr Psychiatry Neurol; 2006 Jun; 19(2):114-7. PubMed ID: 16690997 [TBL] [Abstract][Full Text] [Related]
37. Serum and cerebrospinal fluid proteins and the blood-brain barrier in Alzheimer's disease and multi-infarct dementia. Elovaara I; Palo J; Erkinjuntti T; Sulkava R Eur Neurol; 1987; 26(4):229-34. PubMed ID: 3595662 [TBL] [Abstract][Full Text] [Related]
39. Folate and homocysteine in the cerebrospinal fluid of patients with Alzheimer's disease or dementia: a case control study. Smach MA; Jacob N; Golmard JL; Charfeddine B; Lammouchi T; Ben Othman L; Dridi H; Bennamou S; Limem K Eur Neurol; 2011; 65(5):270-8. PubMed ID: 21474939 [TBL] [Abstract][Full Text] [Related]
40. High plasma levels of cortisol in patients with senile dementia of the Alzheimer's type. Masugi F; Ogihara T; Sakaguchi K; Otsuka A; Tsuchiya Y; Morimoto S; Kumahara Y; Saeki S; Nishide M Methods Find Exp Clin Pharmacol; 1989 Nov; 11(11):707-10. PubMed ID: 2560104 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]